Search in:

Human Vaccines & Immunotherapeutics Volume 8, 2012 - Issue 9: Special Focus: Cancer Commentary Series. Guest Editors: Michael G. Hanna and Alex Kudrin

Submit an article Journal homepage

Free access

2,257

Views

CrossRef citations to date

Altmetric

Commentary

Vaccines against Toxoplasma gondii: Status, challenges and future directions

Qi Liu Department of Parasitology, Shandong University School of Medicine; Jinan, Shandong, P.R. China

Lachhman Das Singla Department of Veterinary Parasitology, College of Veterinary Science, Guru Angad Dev Veterinary and Animal Sciences University; Ludhiana, India

Huaiyu Zhou Department of Parasitology, Shandong University School of Medicine; Jinan, Shandong, P.R. ChinaCorrespondence[email protected]

Pages 1305-1308 | Received 30 May 2012, Accepted 05 Jun 2012, Published online: 21 Aug 2012

Cite this article
https://doi.org/10.4161/hv.21006

Full Article
Figures & data
References
Citations
Metrics
Reprints & Permissions
View PDF PDF

References

Dubey JP. History of the discovery of the life cycle of Toxoplasma gondii.. Int J Parasitol 2009; 39:877 - 82; http://dx.doi.org/10.1016/j.ijpara.2009.01.005; PMID: 19630138
PubMed Web of Science ®Google Scholar
Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363:1965 - 76; http://dx.doi.org/10.1016/S0140-6736(04)16412-X; PMID: 15194258
PubMed Web of Science ®Google Scholar
Jones JL, Dubey JP. Foodborne Toxoplasmosis. Clin Infect Dis 2012; http://dx.doi.org/10.1093/cid/cis508; PMID: 22618566
PubMed Web of Science ®Google Scholar
Serranti D, Buonsenso D, Valentini P. [Congenital toxoplasmosis treatment]. Eur Rev Med Pharmacol Sci 2011; 15:193 - 8; PMID: 21434486
PubMed Web of Science ®Google Scholar
Buxton D, Innes EA. A commercial vaccine for ovine toxoplasmosis. Parasitology 1995; 110:Suppl S11 - 6; http://dx.doi.org/10.1017/S003118200000144X; PMID: 7784124
PubMed Web of Science ®Google Scholar
Kur J, Holec-Gasior L, Hiszczyńska-Sawicka E. Current status of toxoplasmosis vaccine development. Expert Rev Vaccines 2009; 8:791 - 808; http://dx.doi.org/10.1586/erv.09.27; PMID: 19485758
PubMed Web of Science ®Google Scholar
Garcia JL. Vaccination concepts against Toxoplasma gondii.. Expert Rev Vaccines 2009; 8:215 - 25; http://dx.doi.org/10.1586/14760584.8.2.215; PMID: 19196201
PubMed Web of Science ®Google Scholar
Saade F, Petrovsky N. Technologies for enhanced efficacy of DNA vaccines. Expert Rev Vaccines 2012; 11:189 - 209; http://dx.doi.org/10.1586/erv.11.188; PMID: 22309668
PubMed Web of Science ®Google Scholar
Innes EA, Vermeulen AN. Vaccination as a control strategy against the coccidial parasites Eimeria, Toxoplasma and Neospora. Parasitology 2006; 133:Suppl S145 - 68; http://dx.doi.org/10.1017/S0031182006001855; PMID: 17274844
PubMed Web of Science ®Google Scholar
Alexander J, Jebbari H, Bluethmann H, Satoskar A, Roberts CW. Immunological control of Toxoplasma gondii and appropriate vaccine design. Curr Top Microbiol Immunol 1996; 219:183 - 95; PMID: 8791700
PubMed Web of Science ®Google Scholar
Mestas J, Hughes CC. Of mice and not men: differences between mouse and human immunology. J Immunol 2004; 172:2731 - 8; PMID: 14978070
PubMed Web of Science ®Google Scholar
Denkers EY, Gazzinelli RT. Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection. Clin Microbiol Rev 1998; 11:569 - 88; PMID: 9767056
PubMed Web of Science ®Google Scholar
Lang C, Gross U, Lüder CG. Subversion of innate and adaptive immune responses by Toxoplasma gondii.. Parasitol Res 2007; 100:191 - 203; http://dx.doi.org/10.1007/s00436-006-0306-9; PMID: 17024357
PubMed Web of Science ®Google Scholar
Faurez F, Dory D, Le Moigne V, Gravier R, Jestin A. Biosafety of DNA vaccines: New generation of DNA vectors and current knowledge on the fate of plasmids after injection. Vaccine 2010; 28:3888 - 95; http://dx.doi.org/10.1016/j.vaccine.2010.03.040; PMID: 20371391
PubMed Web of Science ®Google Scholar
Klinman DM, Takeshita F, Kamstrup S, Takeshita S, Ishii K, Ichino M, et al. DNA vaccines: capacity to induce auto-immunity and tolerance. Dev Biol (Basel) 2000; 104:45 - 51; PMID: 11713823
PubMedGoogle Scholar
Lai WC, Bennett M. DNA vaccines. Crit Rev Immunol 1998; 18:449 - 84; PMID: 9784969
PubMed Web of Science ®Google Scholar
Liu MA. DNA vaccines: an historical perspective and view to the future. Immunol Rev 2011; 239:62 - 84; http://dx.doi.org/10.1111/j.1600-065X.2010.00980.x; PMID: 21198665
PubMed Web of Science ®Google Scholar
Pulendran B, Ahmed R. Immunological mechanisms of vaccination. Nat Immunol 2011; 12:509 - 17; http://dx.doi.org/10.1038/ni.2039; PMID: 21739679
PubMed Web of Science ®Google Scholar
Higgins SC, Mills KH. TLR, NLR Agonists, and Other Immune Modulators as Infectious Disease Vaccine Adjuvants. Curr Infect Dis Rep 2010; 12:4 - 12; http://dx.doi.org/10.1007/s11908-009-0080-9; PMID: 21308494
PubMedGoogle Scholar
Jongert E, Roberts CW, Gargano N, Förster-Waldl E, Petersen E. Vaccines against Toxoplasma gondii: challenges and opportunities. Mem Inst Oswaldo Cruz 2009; 104:252 - 66; http://dx.doi.org/10.1590/S0074-02762009000200019; PMID: 19430651
PubMed Web of Science ®Google Scholar
Zhou H, Gu Q, Zhao Q, Zhang J, Cong H, Li Y, et al. Toxoplasma gondii: expression and characterization of a recombinant protein containing SAG1 and GRA2 in Pichia pastoris. Parasitol Res 2007; 100:829 - 35; http://dx.doi.org/10.1007/s00436-006-0341-6; PMID: 17058109
PubMed Web of Science ®Google Scholar
Zhou H, Min J, Zhao Q, Gu Q, Cong H, Li Y, et al. Protective immune response against Toxoplasma gondii elicited by a recombinant DNA vaccine with a novel genetic adjuvant. Vaccine 2012; 30:1800 - 6; http://dx.doi.org/10.1016/j.vaccine.2012.01.004; PMID: 22240340
PubMed Web of Science ®Google Scholar
Weiss LM, Fiser A, Angeletti RH, Kim K. Toxoplasma gondii proteomics. Expert Rev Proteomics 2009; 6:303 - 13; http://dx.doi.org/10.1586/epr.09.16; PMID: 19489701
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Vaccines against Toxoplasma gondii: Status, challenges and future directions

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Vaccines against Toxoplasma gondii: Status, challenges and future directions

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date